AEG-1 is frequently upregulated in multiple human malignancies, such as breast cancer, hepatocellular carcinoma, non-small cell lung cancer and prostate cancer, and is correlated with disease progression and poor clinical outcomes (21–24). The gene discussed is MTDH; the disease is hepatocellular carcinoma.